Did you deliver a child with birth defects after taking GlaxoSmithKline’s popular anti-nausea drug, Zofran?

Recent medical studies have associated a distressing link between Zofran’s active ingredient, ondansetron, and several fetal malformations, including cleft palate and congenital heart defects.

Allegations that GlaxoSmithKline hid similar results from the FDA, physicians and pregnant women are now set forth in lawsuits filed against the company.

Considering the US Department of Justice’s legal claims that GSK illegally marketed Zofran for unapproved use during early pregnancy, you may also believe that the pharmaceutical giant should be held liable.

You may be right. If you took Zofran during your first trimester, and then gave birth to a child with cleft palate, congenital heart defects, or any other birth defects, contact us and we will investigate if you have a strong case against GlaxoSmithKline.

Why Should I Choose Monheit Law For My Zofran Birth Defect Lawsuit?

Taking on a true pharmaceutical giant like GlaxoSmithKline is very different from suing a private individual. GSK has vast financial resources and the ability to retain an aggressive defense team devoted to denying liability at every turn. GSK is already denying that they did anything improper with the sale of Zofran and the promotion of the drug to OB/GYNs.

If you hope to secure justice for your family, you’ll need an equally accomplished group of litigators on your side. Your choice of attorney is crucial, now more than ever.

Michael Monheit, Esq.

A plaintiff’s attorney with over 20 years of trial experience, Michael Monheit is the managing partner of Monheit Law. Focused on cases that involve dangerous pharmaceutical products, Michael’s practice often brings him up against the world’s largest manufacturers. In all cases, Michael fights for the rights of individuals, while promoting greater corporate accountability.

Over the course of his career, Michael has become nationally-recognized for his work.

In 2007, he was chosen by the American Association for Justice to chair the Fosamax Litigation Group. This far-reaching class action sought justice for individuals and families harmed by Fosamax, an osteoporosis drug produced by one of the world’s largest pharmaceutical corporations, Merck & Co.

Before that, Michael served on the Plaintiff’s Steering and Executive Committee in MDL 1148, a class action that sought accountability in the latex industry. He has also been lead counsel in several class actions filed against public housing authorities on behalf of children who suffered lead paint poisoning. These legal actions eventually extended to involve the lead paint industry itself.

As the father of a child with special needs, Michael understands the wide array of emotions that the parents of children with developmental delays experience. He currently sits on the board for The Cleft Lip And Palate Foundation of Smiles, and frequently lends assistance to parents whose children were born with orofacial defects.

Co-Counsel In Zofran Birth Defect Litigation

You don’t have to do this alone, and neither do we. Monheit Law has partnered with multiple law firms, all of whom have experience litigating mass torts, to pursue Zofran birth defect lawsuits against GlaxoSmithKline.

Elizabeth Graham, Esq.

Elizabeth Graham is a director at Grant & Eisenhofer, and leads their complex pharmaceutical litigation practice. For over 25 years, she has devoted her legal practice to class actions.

Ms. Graham has been appointed lead counsel in many notable cases. In Borman Automotive v. American Honda Motor Corp., she was instrumental in securing a settlement of $435 million. Her representation of over 100 families harmed by environmental toxins has secured confidential settlements valued at more than $25 million.

Ms. Graham represented multiple families in a class action against Sulzer Orthopedics, Inc., a prosthetic hip manufacturer whose defective medical devices victimized tens of thousands. The case eventually settled for more than $1 billion.

Robert Jenner, Esq.

Robert Jenner leads the Mass Tort practice at the law firm of Janet, Jenner & Suggs, LLC. With more than 28 years of experience, Mr. Jenner focuses on cases involving harmful prescription medications and medical devices.

He is frequently honored by the peer-reviewed legal network Best Lawyers as one of America’s top Mass Tort and Class Action litigators. Mr. Jenner currently co-chairs the American Association for Justice’s Zofran Litigation Group.

Brian Mittman, Esq.

Brian Mittman is partner at the New York law firm of Markhoff & Mittman, P.C. and has represented injury victims for more than 20 years.

A devoted family man, Brian helps raise money and awareness for the Pediatric Cancer Foundation.

Laurence Banville, Esq.

As the managing partner at Banville Law, and a former defense attorney for asbestos manufacturers, Laurence Banville brings the team at Monheit Law a detailed understanding of how large companies attempt to deny liability.

Born in southern Ireland, Mr. Banville has been named to the Irish Legal 100, a prestigious group of the hundred most outstanding attorneys of Irish descent. He was also honored as one of National Trial Lawyers’ “Top 40 Under 40.”